Immunohistochemistry (IHC) analysis showed that treatment with matrine resulted in a remarkably smaller proportion of Ki-67 (proliferation marker protein) and CD31 (antigen involved in angiogenesis) positive ovarian carcinoma cells in tumors compared with the control group (Fig. 6d). Here, MKI67 is linked to ovarian carcinoma.